Skip to content
OpenCapital
Get started

Repligen RGEN Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value

Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value at other companies

Repligen logo
RepligenRGEN
$129.34—
SS&C Technologies logo
SS&C TechnologiesSSNC
$97.28+43.3%
Repligen logo
RepligenRGEN
$65.80-18.2%
VeriSign logo
VeriSignVRSN
$226.12+16.1%
Ford Motor Company logo
Ford Motor CompanyF
$10.54-15.6%
PNC Financial Services logo
PNC Financial ServicesPNC
$190.93+34.7%

Other financials

Income statement

See full
Revenue$194.3M+14.8%
Gross profit$108.3M+18.5%
Operating income$15.9M+142%
Net income$8.3M+42.9%
EPS (diluted)$0.15+50.0%

Balance sheet

See full
Cash & equivalents$582.7M-16.4%
Total debt$687.6M+346%
Total equity$2.1B+6.0%
Total assets$2.9B+2.8%

Cash flow

See full
Operating cash flow$28.3M+88.6%
CapEx$4.7M+32.2%
Free cash flow$23.6M+106%

Valuation

See full
Market cap$7.45B-7.1%
Enterprise value$7.55B+2.1%
P/E144.9×—
P/S10.1×-0.1×

Profitability

See full
Gross margin49.5%+2.7pp
Operating margin1.5%-14.0pp
Net margin17.1%-3.7pp
FCF margin21.2%+6.1pp

Returns & leverage

See full
Return on equity2.5%+1.9pp
Debt / equity0.3×+0.2×
Current ratio9.2×+2.4×

Where this comes from

Reported directly by Repligen in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue.

The official record: Repligen’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Repligen's share based compensation arrangement by share based payment award options grants in period weighted average grant date fair value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Repligen's share based compensation arrangement by share based payment award options grants in period weighted average grant date fair value?
Repligen (RGEN) reported share based compensation arrangement by share based payment award options grants in period weighted average grant date fair value of $65.80 in Q1 2026.
How has Repligen's share based compensation arrangement by share based payment award options grants in period weighted average grant date fair value changed year-over-year?
Repligen's share based compensation arrangement by share based payment award options grants in period weighted average grant date fair value decreased by 18.2% year-over-year, from $80.40 to $65.80.
What does share based compensation arrangement by share based payment award options grants in period weighted average grant date fair value mean?
The average fair value per share assigned to stock options on the date they were granted, determined using standard option pricing models. This value is used to amortize the total compensation expense over the vesting period of the awards. It provides a standardized measure of the cost the company incurs for each unit of equity-based compensation granted.